We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-18.63%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.03B
AUM Growth
-$689M
Cap. Flow
-$116M
Cap. Flow %
-5.7%
Top 10 Hldgs %
20.08%
Holding
282
New
27
Increased
73
Reduced
123
Closed
38

Top Buys

Rank Stock Value
1
GDOT icon
Green Dot
GDOT
+$23.4M
2
CHDN icon
Churchill Downs
CHDN
+$20.7M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$18.4M
4
NSP icon
Insperity
NSP
+$16.1M
5
TDOC icon
Teladoc Health
TDOC
+$14.2M

Top Sells

Rank Stock Value
1
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$25.4M
2
IMPV
Imperva, Inc.
IMPV
+$23.8M
3
FCB
FCB Financial Holdings, Inc.
FCB
+$23.6M
4
IDTI
Integrated Device Technology I
IDTI
+$23.6M
5
KYNB
Kyntra Bio
KYNB
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.19%
2 Technology 18.37%
3 Consumer Discretionary 18.29%
4 Industrials 14.17%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
101
Tectonic Therapeutic
TECX
$615M
$6.34M 0.31%
31,720
+189
+0.6% +$57.6K
CRS icon
102
Carpenter Technology
CRS
$27.7B
$6.14M 0.3%
172,521
-269,787
-61% -$12.2M
KMT icon
103
Kennametal
KMT
$2.57B
$6.06M 0.3%
182,133
-483,314
-73% -$18.3M
YETI icon
104
Yeti Holdings
YETI
$3.87B
$5.87M 0.29%
+395,805
New +$6.28M
ADMS
105
DELISTED
Adamas Pharmaceuticals
ADMS
$5.55M 0.27%
650,349
-12,195
-2% -$159K
TFIN icon
106
Triumph Financial Inc
TFIN
$1.92B
$5.34M 0.26%
179,808
-275,870
-61% -$9.74M
ZS icon
107
Zscaler
ZS
$24.2B
$5.24M 0.26%
133,742
-638
-0.5% -$24.1K
FFWM
108
DELISTED
First Foundation Inc
FFWM
$5.04M 0.25%
392,254
-130,414
-25% -$1.97M
EVRI
109
DELISTED
Everi Holdings
EVRI
$4.92M 0.24%
956,141
-18,032
-2% -$123K
CTLP
110
DELISTED
Cantaloupe
CTLP
$4.85M 0.24%
1,246,935
-41,290
-3% -$217K
TWST icon
111
Twist Bioscience
TWST
$5.84B
$3.8M 0.19%
+164,747
New +$3.65M
DK icon
112
Delek US
DK
$3.88B
$3.26M 0.16%
100,289
-380,074
-79% -$14.4M
NSLR
113
Neostellar Capital Corp
NSLR
$270M
$2.97M 0.15%
678,224
-26,615
-4% -$147K
CUTR
114
DELISTED
Cutera, Inc.
CUTR
$2.69M 0.13%
158,091
+925
+0.6% +$18.9K
USX
115
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$2.69M 0.13%
479,566
-584,936
-55% -$4.91M
PH icon
116
Parker-Hannifin
PH
$120B
$2.19M 0.11%
14,684
-2,569
-15% -$416K
BURL icon
117
Burlington
BURL
$21.7B
$2.17M 0.11%
13,357
-2,373
-15% -$383K
CNK icon
118
Cinemark Holdings
CNK
$3.55B
$2.03M 0.1%
56,759
-9,770
-15% -$386K
FDC
119
DELISTED
First Data Corporation
FDC
$2.02M 0.1%
119,232
+33,049
+38% +$644K
PANW icon
120
Palo Alto Networks
PANW
$292B
$2.01M 0.1%
64,170
-11,118
-15% -$347K
RCL icon
121
Royal Caribbean
RCL
$77B
$1.96M 0.1%
20,000
-1,932
-9% -$212K
INAP
122
DELISTED
Internap Corporation
INAP
$1.91M 0.09%
461,108
-15,320
-3% -$114K
MSFT icon
123
Microsoft
MSFT
$2.93T
$1.91M 0.09%
18,819
+1,279
+7% +$137K
PTC icon
124
PTC
PTC
$14.4B
$1.75M 0.09%
21,174
-866
-4% -$76K
AMZN icon
125
Amazon
AMZN
$2.66T
$1.75M 0.09%
23,280
– –
3 4
5
6 7

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, Emerald Advisers held 282 positions worth $2.03B, down 25% from $2.72B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers withdrew a net $116M in Q4 2018, closing 38 positions and reducing 123 holdings. Its most notable exit was G1 Therapeutics, Inc. Common Stock, an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Green Dot worth $23.6M.

  • Emerald Advisers's largest Q4 2018 buy was Green Dot: 296,199 shares worth $23.6M.
  • Emerald Advisers added most to Teladoc Health in Q4 2018, an estimated $14.2M increase.
  • Emerald Advisers's biggest Q4 2018 reduction was Kennametal, cutting an estimated $18.3M.
  • Emerald Advisers fully exited G1 Therapeutics, Inc. Common Stock in Q4 2018, selling an estimated $25.4M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.03B portfolio in Q4 2018.
  • Emerald Advisers opened 27 new positions and closed 38 in Q4 2018.
  • Emerald Advisers's portfolio value fell 25% quarter-over-quarter to $2.03B.

Based on Emerald Advisers's 13F filing for Q4 2018, filed 30 Jan 2019.